Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Novacyt

NVYTF
Current price
0.96 USD 0 USD (0.00%)
Last closed 0.83 EUR
ISIN FR0010397232
Sector Healthcare
Industry Medical Devices
Exchange PA
Capitalization 56 752 703 EUR
Yield for 12 month +3.37 %
1Y
3Y
5Y
10Y
15Y
NVYTF
21.11.2021 - 28.11.2021

Novacyt S.A., together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, France, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Yourgene Health, and IT-IS International segments. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The IT-IS International segment develops and manufactures PCR devices for the life sciences and food testing industry. The company was incorporated in 2006 and is based in Eastleigh, the United Kingdom. Address: York House, Eastleigh, United Kingdom, SO53 4DG

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3.7 EUR

P/E ratio

Dividend Yield

Current Year

+13 657 428 EUR

Last Year

+24 816 675 EUR

Current Quarter

+11 258 907 EUR

Last Quarter

+2 291 698 EUR

Current Year

+4 399 534 EUR

Last Year

+6 777 406 EUR

Current Quarter

-1 270 725 EUR

Last Quarter

+1 142 761 EUR

Key Figures NVYTF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -19 796 994 EUR
Operating Margin TTM -278.75 %
PE Ratio
Return On Assets TTM -13.43 %
PEG Ratio
Return On Equity TTM -27.46 %
Wall Street Target Price 3.7 EUR
Revenue TTM 11 534 715 EUR
Book Value 1.23 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 81.8 %
Dividend Yield
Gross Profit TTM 5 724 024 EUR
Earnings per share -0.46 EUR
Diluted Eps TTM -0.46 EUR
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY -97.1 %
Profit Margin -244.34 %

Dividend Analytics NVYTF

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History NVYTF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation NVYTF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.6329
Price Sales TTM 4.9202
Enterprise Value EBITDA -9.1851
Price Book MRQ 0.5647

Financials NVYTF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators NVYTF

For 52 weeks

0.45 EUR 1.58 EUR
50 Day MA 0.75 EUR
Shares Short Prior Month
200 Day MA 0.67 EUR
Short Ratio
Shares Short
Short Percent